Israel Barken, MD 7/26/2017
Education:
1967-1974 Hadassah Medical School Hebrew University of Jerusalem Surgical Residency
1976-1977 Surgical Residency, Assaf Harofe Tel Aviv. Surgical Residency
1977-1978 General Surgery, Loyola University St Francis Hospital, Evanston, Illinois Surgical Residency
1978-1980 General Surgery, Washington University St Louis, MO. Urology Residency
1980-1983 Urology, Washington University Barnes Hospital, St. Louis MO. Academic Position
1983-1986 Associate in Surgery, Urology Division University of Arizona, Tucson, AZ. Academic Position
1986-present Clinical Professor University of California San Diego. Medical Practice
1983-1986 Cigna Health Plan Tucson, AZ Medical Practice
1986-2001 Private Practice, Alvarado Hospital San Diego, CA Nonprofit Activity
1997-present Chairman and Medical Director Prostate Cancer Research and Education Foundation Business Activity
2015-present Chairman and Cofounder Innovative Global Technology, www.IglobalT.com Business Activity
2016-present Medical Director Dalian High -Tech Zone Science Innovation Center Business Activity 2016-present Medical Director Harmony Global Group, LLC PROFESSIONAL SOCIETIES Diplomate, American Board of Urology Fellow, American College of Surgeons Fellow, American Society for Laser in Medicine and Surgery American Urological Association Society of Urologic Cryosurgeons
US PATENTS:
4672963 06/1986 Method and Apparatus for Computerized Laser
5377683 01/1995 Ultrasound-Laser Surgery Method & Apparatus
5531742 07/1996 Method & Apparatus for Computerized Cryosurgery
U.S. PATENTS PENDING, MEDICAL:
ADOPTIVE CELL THERAPY WITH SPECIFIC REGULATORY LYMPHOCYTES; 7012-005; USSN 13/904,010; Filing Date 05-28-2013.
METHODS OF TREATING DISEASES; 7012-006; USSN 13/970,537; US 2014-0065629 A1; Filing Date 08-19-2013.
METHOD TO AUGMENT IMMUNE SYSTEM IN RESPONSE TO DISEASE OR INJURY; 7012-007; USSN 13/971,847; US 2014-0065098 A1; Filing Date 08-21-2013.
METHOD FOR TREATING CANCER BY COMBINING EXTERNAL ENERY AND IMMUNOLOGICAL PHARMACOLOGICAL APPLICATION.US 62/403,163; 10-02-2016
U.S. PATENTS PENDING, SOFTWARE:
INTERACTIVE GRAPHIC ELECTRONIC MEDICAL RECORDS. Application number- 14479302. EFS I.D- 20066767. Filing Date 09-06-2014.
INTERACTIVE GRAPHIC ELECTRONIC CLINICAL STUDY MANAGEMENT Application No 14574390. EFS I.D. 20997510. Filing Date 12-17- 2014.
JOURNAL ARTICLES:
Long-term evaluation of tamsulosin in benign prostatic hyperplasia: placebo-controlled, double-blind extension of phase III trial
Urology. 1998 Jun;51(6):901-6.
Herbert Lepor, for the Tamsulosin Investigator Group. Israel Barken, San Diego, CA
Safety and efficacy of exisulind for treatment of recurrent prostate cancer after radical prostatectomy
J Urol. 2001 Sep;166(3):882-6
Goluboff ET, Prager D Rukstalis D, Giamtonio B, Madorsky M, Barken I, Weinstein IB, Partin AW, Olsson CA
Time-dependent effects of hormone-deprivation therapy on prostate metabolism as detected by combined magnetic resonance imaging and 3D magnetic resonance spectroscopic imaging.
Magn Reson Med. 2001 Jul;46(1):49-57.
Mueller-Lisse UG, Swanson MG, Vigneron DB, Hricak H, Bessette A, Males RG, Wood PJ, Noworolski S, Nelson SJ, Barken I, Carroll PR
Direct evidence that PTHrP expression promotes prostate cancer progression in bone
Biochem Biophys Res Commun. 2005 Feb 11;327(2):468-72
Deftos LJ, Barken I, Burton DW, Hoffman RM, Geller J.
Monitoring of skeletal progression of prostate cancer by GFP imaging, X-ray, and serum OPG and PTHrP
Prostate. 2005 Feb 15;62(3):275-81.
Burton DW, Geller J, Yang M, Jiang P, Barken I, Hastings RH, Hoffman RM, Deftos LJ
Noscapine Inhibits Human Prostate Cancer Progression and Metastasis in Mouse Model Anticancer Research 28:3701-3704, (2008)
Barken I, Geller J, Rogosnitzky M
Prophylactic Noscapine Therapy Inhibits Human Prostate Cancer Progression and Metastasis in Mouse Model
Anticancer Research 30:399-403, (2010)
Barken I, Geller J, Rogosnitzky M
The effect of two soy preparations on PSA levels in patients with prostate cancer and the correlation of PSA changes with plasma genistein.
The 3rd Annual International Soy Meeting, Washington, D.C., Oct 31-Nov 3, 1999.
- Barken, M.D., E. Baranov, Ph.D., J. Geller, M.D.: San Diego, Ca
PTHrP Expression Promotes Prostate Cancer Progression in Bone
American Federation for Medical Research, Western Regional Mtg, Carmel, CA. Jan. 2003.
LJ Deftos, I Barken, DW Burton, and J Geller.
PTHrP and Cancer Progression in Bone
4th International Conf. on Cancer Induced Bone Disease, San Antonio, TX. Dec. 7-9, 2003.
L.J. Deftos, I. Barken, D.W. Burton, and J. Geller.
CONFERENCE POSTERS:
Tumor enriched immunocytochemical assay for the detection of circulating breast and prostate cancer cells in patients' peripheral blood (PB)
ASCO 2000, New Orleans, LA May 20-23, 2000
- Umiel, A Albayan, M. Priluskaha, R Vantanparast, I. Barken, S Geroge, T.J.Moss
Cancer Progression in Bone by PTHrP.
25th Annual Meeting of the American Society for Bone and Mineral Research. Journal of Bone and Mineral Research, v.18, n.SUPPL. 2, S199, (2003).
- W. Burton, I. Barken, J. Geller, R. M. Hoffman, L. J. Deftos. Regulation of Prostate
Hormone Ablation of Localized Prostate Cancer: Effects of Duration of Therapy on Prostate Metabolism Demonstrated by 3D 1H MR Spectroscopy
7th Annual Meeting of the International Society for Magnetic Resonance in Medicine, Philadelphia, Pennsylvania, 3:1518, 1999.
Mueller-Lisse, UG, Kurhanewicz, J, Bessette, A, Males, R, Swanson, M, Fang, A, Nelson, S, Hricak, H, Barken, I, and Vigneron, DB.
Localization of Prostate Cancer After Hormone Ablation by MRI and 3D 1H MRSI: Case-Control Study with Pathologic Correlation
7th Annual Meeting of the International Society for Magnetic Resonance in Medicine, Philadelphia, Pennsylvania, 3:1519, 1999
Bessette, A, Mueller-Lisse, UG, Swanson, M, Vigneron, DV, Scheidler, J, Srivastava, A, Wood, P, Hricak, H, Barken, I, Carroll, P, Nelson, SJ, and Kurhanewicz, J.
SERVICE BOARDS:
Chairman of the Board, Prostate Cancer Research and Education Foundation, 501(c)(3)
Member of the Board, National Prostate Cancer Coalition 1997-1999
Member of the Board, Education Center for Prostate Cancer Patients
Volunteer and speaker, American Cancer Society
Board member of the Medical Advisory Board of PAACT
Board member of the Medical Advisory of U.S Too organization
EDUCATIONAL ACTIVITIES:
Ask Dr. Barken Weekly Calling Show. May 2005 – May 2013
AskDrBarken Weekly Video Blog - AskDrBarken.WordPress.com
Monthly support group for prostate cancer patients since 1986
Running Medical Smart Chart, a web- based electronic medical chart
Coaching services for patients with prostate cancer and their families
Web meetings with patients from different parts of the world
AREAS OF INTEREST:
Medical Device Development
Cryotherapy
Electroporation and Electrolysis
Medical Software for Data Collection
Stem Cells
Novel Immunotherapy and Theranostics
Contact Informaton:
Isreal Barken, MD
"The Coach"
PCREF, 6823 Deer Hollow Pl, San Diego, CA. 92120
619-906-4700
Email: info@pcref.org